Intravenous Infusion Pump Market - By Product Type: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia (PCA) Pumps; By Application: Oncology, Pain Management, Diabetes Management, Nutrition, Others (Anesthesia, Neonatal Care); By End User: Hospitals, Ambulatory Surgery Centers, Home Healthcare, Specialty Clinics; By Region: North America, Europe, Asia-Pacific Latin America and Others
1 | Market Overview
The global intravenous infusion pump market is steadily growing due to the increasing demand for precise and controlled drug delivery in hospitals, outpatient settings, and home care. Infusion pumps are utilized to administer fluids, medications, and nutrients at controlled rates, making them essential in intensive care units (ICUs), oncology, pain management, and neonatal care.
Technological advancements—such as smart pumps with dose error reduction software (DERS), wireless connectivity, and integration with electronic medical records (EMRs)—have improved safety and usability. The market is also benefiting from an aging global population, a rising chronic disease burden, and an increasing shift to outpatient and home-based care.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
8.7 |
Historical benchmark |
|
2024 |
13.4 |
Five-year CAGR 9.0% |
|
2031 |
26.2 |
Seven-year CAGR 10.1% |
The market is expected to nearly double by 2031, driven by smart pump innovation, healthcare digitization, and global critical care infrastructure expansion.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The infusion pump market is consolidated, featuring key players that provide comprehensive infusion systems, integration solutions, and service portfolios.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Becton Dickinson (BD) |
28% |
Alaris™ System with Guardrails™ safety software |
|
Baxter International |
24% |
Sigma Spectrum™ Infusion System |
|
ICU Medical |
19% |
Plum 360™, LifeCare™ PCA systems |
|
Fresenius Kabi |
11% |
Volumat™ and Agilia™ lines |
|
Others (Smiths Medical, Moog, Mindray) |
18% |
Niche, regional, and portable devices |
6 | Market Segmentation
By Product Type:
By Application:
By End User:
By Region:
7 | Strategic Outlook
Market expansion will be bolstered by AI-powered dose calculators, cloud-based pump monitoring, and integration into wider health IT ecosystems. Competitive advantage will hinge on interoperability, service contracts, and training support
Need help?
Chat with our team in a minute.